Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclax

Ahmed AribiDepartment Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USACorrespondence[email protected]

Amandeep SalhotraDepartment Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA

https://orcid.org/0000-0002-9302-5041

Brian BallDepartment Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA

Anthony SteinDepartment Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA

Guido MarcucciDepartment Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA

Vinod PullarkatDepartment Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA, USA

Click to increase image sizeClick to decrease image size

Disclosure statement

Vinnod Pullarkat: Abbvie advisory and consultation. Ahmed Aribi, Amandeep Salhotra, Brian Ball, Guido Marcucci, Anthony Stein no relevant disclosure to the study. No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclax

Information for

Open access

Opportunities

Help and information

Report of four acute myeloid leukemia patients with sustained complete remission with less frequent administration of decitabine and venetoclax

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature